首页> 外文期刊>Clinical Hypertension >Massive pulmonary thromboembolism combined with transient thyrotoxicosis in an 18?year old girl
【24h】

Massive pulmonary thromboembolism combined with transient thyrotoxicosis in an 18?year old girl

机译:巨大的肺血栓栓塞与18岁的肺病联合血清毒毒症

获取原文
           

摘要

Abstract Background Pulmonary thromboembolism (PTE) is thought to usually stem from deep vein thrombosis (DVT). However, evidence of DVT could not be found in many cases. Furthermore, transient thyrotoxicosis is a rare but potentially life–threatening emergency involving a systemic hypercoagulable state. We report on an 18?year-old-girl with transient thyrotoxicosis with massive PTE without DVT. Case presentation An 18-year-old girl was admitted to the hospital with syncope. Patient had no history of trauma, any known underlying disease or oral contraceptives use. Chest computed tomography (CT) showed massive PTE in both central pulmonary arteries and diffuse goiter. However, a low extremity Doppler sonogram did not detect DVT. To manage the PTE, we administered low molecular weight heparin. On the other hands, thyroid function test indicated a state of thyrotoxicosis. In addition, patient had a partial protein S deficiency but no other immunologic abnormality. Therefore, the patient was diagnosed with massive PTE, thyrotoxicosis, and partial protein S deficiency. Patient was discharged with oral warfarin and methimazole. A follow-up echocardiogram obtained 3?months after anticoagulation therapy demonstrated normal dimensions and systolic function. After thyrotoxicosis was treated with methimazole for a month, a euthyroid state was achieved and the goiter decreased to a normal size. The methimazole was gradually tapered off and stopped at 4?months. At a 6-month follow up visit, PTE and pulmonary hypertension had disappeared but the patient still had a partial protein S deficiency. We decided to stop all medication with careful monitoring. During a 4-year follow-up period after the episode, she was asymptomatic without any evidence of recurrent systemic thromboembolism or hyperthyroidism. Conclusions Early recognition and appropriate treatment of PTE combined with transient thyrotoxicosis were vital to preventing other complications.
机译:摘要背景肺血栓栓塞(PTE)被认为通常源于深静脉血栓形成(DVT)。但是,在许多情况下无法找到DVT的证据。此外,短暂的溶毒性病是一种罕见但潜在的危及生命的紧急情况,涉及系统性高凝态。我们报告了18岁?岁女孩,患有瞬态溶毒性毒病,没有DVT的巨大PTE。案例演讲是一个18岁的女孩被晕厥的医院被录取。患者没有创伤的历史,任何已知的潜在疾病或口服避孕药使用。胸部计算断层扫描(CT)在中央肺动脉和漫射孔中显示出大规模的PTE。然而,低端多普勒音谱图没有检测到DVT。管理PTE,我们施用低分子量肝素。另一方面,甲状腺功能试验表明了甲状腺毒性的状态。此外,患者患有部分蛋白质的缺乏,但没有其他免疫学异常。因此,患者被诊断出患有大规模的PTE,甲状腺毒性和部分蛋白质缺乏。患者用口服华法林和甲巯基排出。在抗凝治疗后3个月获得后续超声心动图显示正常尺寸和收缩功能。用甲基唑处理甲基唑杆菌一次,实现了Euthyroid状态,并且甲状腺肿降低到正常尺寸。甲基唑逐渐逐渐减少并停止在4个月。在6个月的后续访问中,PTE和肺动脉高压消失,但患者仍有部分蛋白质S缺乏症。我们决定通过仔细监测阻止所有药物。在第4年的随访期间,她无症状,没有任何经常发育的全身血栓栓塞或甲状腺功能亢进的证据。结论早期识别和适当治疗PTE与瞬时甲状腺杀菌症相结合对预防其他并发症至关重要。

著录项

获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号